Population analysis and epidemiological features of inhibitor-resistant- TEM-β-lactamase-producing Escherichia coli isolates from both community and hospital settings in Madrid, Spain

Journal of Clinical Microbiology

Volumn 48, Issue 7, 2010, Pages 2368-2372

  Martín, Oihane ^a   Valverde, Aránzazu ^a   Morosini, María I ^a   Rodríguez Domínguez, Mario ^a   Rodríguez Baños, Mercedes ^a   Coque, Teresa M ^a   Cantón, Rafael ^a   Del Campo, Rosa ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE TEM 1; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; NALIDIXIC ACID; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE; ESCHERICHIA COLI PROTEIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOSPITAL PATIENT; HUMAN; INHIBITOR RESISTANT TEM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTPATIENT; PHYLOGENY; PLASMID; POPULATION RESEARCH; POPULATION STRUCTURE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPAIN; ANTIBIOTIC RESISTANCE; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA SEQUENCE; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; PLASMIDS; SEQUENCE ANALYSIS, DNA; SPAIN;

EID: 77954428607     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00608-10     Document Type: Article

References (34)

1. Barton, B. M., G. P. Harding, and A. J. Zuccarelli. 1995. A general method for detecting and sizing large plasmids. Anal. Biochem. 226:235-240.
2. Blanco, M., M. P. Alonso, M. H. Nicolas-Chanoine, G. Dahbi, A. Mora, J. E. Blanco, C. López, P. Cortés, M. Llagostera, V. Leflon-Guibout, B. Puentes, R. Mamani, A. Herrera, M. A. Coira, F. García-Garrote, J. M. Pita, and J. Blanco. 2009. Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 63:1135-1141.
3. Cantón, R., M. Pérez-Vázquez, A. Oliver, B. Sánchez Del Saz, M. O. Gutie ́rrez, M. Martínez-Ferrer, and F. Baquero. 2000. Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing. J. Clin. Microbiol. 38:1339-1346.
4. Cantón, R., M. I. Morosini, O. M. de la Maza, and E. G. de la Pedrosa. 2008. IRT and CMT β-lactamases and inhibitor resistance. Clin. Microbiol. Infect. 14(Suppl. 1):53-62.
5. Carattoli, A., A. Bertini, L. Villa, V. Falbo, K. L. Hopkins, and E. J. Threlfall. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228.
6. Chaïbi, E. B., D. Sirot, G. Pauland, and R. Labia. 1999. Inhibitor-resistant TEM β-lactamases: phenotypic, genetic and biochemical characteristics. J. Antimicrob. Chemother. 43:447-458.
7. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
8. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard. Eighth edition. Document M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Clinical and Laboratory Standards Institute. 2009. Performance and standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
10. DebRoy, C., M. S. Sidhu, U. Sarker, B. M. Jayarao, A. L. Stell, N. P. Bell, and T. J. Johnson. 2010. Complete sequence of pEC14-114, a highly conserved IncFIB/FIIA plasmid associated with uropathogenic Escherichia coli cystitis strains. Plasmid 63:53-60.
11. Duck, W. M., C. D. Steward, S. N. Banerjee, J. E. McGowan, Jr., and F. C. Tenover. 2003. Optimization of computer software settings improves accuracy of pulsed-field gel electrophoresis macrorestriction fragment pattern analysis. J. Clin. Microbiol. 41:3035-3042.
12. Genoscope. 2008. Direct submission to the NCBI database of Escherichia coli UMN026 genome sequence project. Accession number CU928148. Centre National de Sequencage, Evry, France.
13. González-Zorn, B., A. Catalan, J. A. Escudero, L. Domínguez, T. Teshager, C. Porrero, and M. A. Moreno. 2005. armA and aminoglycoside resistance in Escherichia coli. Emerg. Infect. Dis. 11:954-956.
14. Guerineau, J. F., P. M. Mullineaux, and E. W. Parnell. Patent EP 0369637-A1. 23 May 1990. Sulfonamide resistance genes and their use. Advanced Technologies (Cambridge) Ltd.; Agricultural Genetics Company Limited; Biotal Limited; BP Nutrition Ltd.; Ciba-Geigy plc; Imperial Chemical Industries plc; Rhone-Poulenc Ltd.; Schering Agrochemicals Limited; Shell Research Limited; Twyford Seeds Ltd.; and Unilever United Kingdom Central Resources Ltd.
15. Johnson, J. R., S. Miller, B. Johnston, C. Clabots, and C. Debroy. 2009. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J. Clin. Microbiol. 47:3721-3725.
16. Kaufmann, M. E. 1998. Pulsed-field-electrophoresis, p. 33-50. In N. Woodford and A. P. Johnson (ed.), Molecular bacteriology. Protocols and clinical applications. Humana Press, Totowa, NJ.
17. Lau, S. H., S. Reddy, J. Cheesbrough, F. J. Bolton, G. Willshaw, T. Cheasty, A. J. Fox, and M. Upton. 2008. Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J. Clin. Microbiol. 46:1076-1080.
18. Leflon-Guibout, V., J. Blanco, K. Amaqdouf, A. Mora, L. Guize, and M. H. Nicolas-Chanoine. 2008. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J. Clin. Microbiol. 46: 3900-3905.
19. Lescat, M., A. Calteau, C. Hoede, V. Barbe, M. Touchon, E. Rocha, O. Tenaillon, C. Médigue, J. R. Johnson, and E. Denamur. 2009. A module located at a chromosomal integration hot spot is responsible for the multidrug resistance of a reference strain from Escherichia coli clonal group A. Antimicrob. Agents Chemother. 53:2283-2288.
20. Liu, S. L., A. Hessel, and K. E. Sanderson. 1993. Genomic mapping with I-Ceu I, an intron-encoded endonuclease specific for genes for ribosomal RNA, in Salmonella spp., Escherichia coli, and other bacteria. Proc. Natl. Acad. Sci. U. S. A. 90:6874-6878.
21. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
22. Mabilat, C., and S. Goussard. 1995. PCR detection and identification of genes for extended-spectrum ß-lactamases, p. 553-557. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology. Principles and applications. American Society for Microbiology, Washington, DC.
23. Marcadé, G., C. Deschamps, A. Boyd, V. Gautier, B. Picard, C. Branger, E. Denamur, and G. Arlet. 2009. Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases. J. Antimicrob. Chemother. 63: 67-71.
24. Miró, E., F. Navarro, B. Mirelis, M. Sabaté, A. Rivera, P. Coll, and G. Prats. 2002. Prevalence of clinical isolates of Escherichia coli producing inhibitorresistant β-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period. Antimicrob. Agents Chemother. 46:3991-3994.
25. Novais, A., R. Cantón, R. Moreira, L. Peixe, F. Baquero, and T. M. Coque. 2007. Emergence and dissemination of Enterobacteriaceae isolates producing CTX-M-1-like enzymes in Spain are associated with IncFII (CTX-M-15) and broad-host-range (CTX-M-1, -3, and -32) plasmids. Antimicrob. Agents Chemother. 51:796-799.
26. Oliver, A., M. Pérez-Vázquez, M. Martínez-Ferrer, F. Baquero, L. de Rafael, and R. Cantón. 1999. Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different β-lactam resistance phenotypes. Antimicrob. Agents Chemother. 43:862-867.
27. Oteo, J., K. Diestra, C. Juan, V. Bautista, A. Novais, M. Pérez-Vázquez, B. Moyá, E. Miró, T. M. Coque, A. Oliver, R. Cantón, F. Navarro, J. Campos, and Spanish Network in Infectious Pathology Project (REIPI). 2009. Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/ A, ST23 complex/A and ST131/B2. Int. J. Antimicrob. Agents 34:173-176.
28. Pitout, J. D., D. B. Gregson, L. Campbell, and K. B. Laupland. 2009. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli causing bacteraemia in the Calgary Health Region 2000-2007: the emergence of clone ST131 as a cause of community-acquired infections. Antimicrob. Agents Chemother. 53:2846-2851.
29. Pomba, C., J. D. da Fonseca, B. C. Baptista, J. D. Correia, and L. Martínez-Martínez. 2009. Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6′)-Ib-cr genes in a dog. Antimicrob. Agents Chemother. 53:327-328.
30. Szczepanowski, R., S. Braun, V. Riedel, S. Schneiker, I. Krahn, A. Pühler, and A. Schlüter. 2005. The 120.592 bp IncF plasmid pRSB107 isolated from a sewage-treatment plant encodes nine different antibiotic-resistance determinants, two iron-acquisition systems and other putative virulence-associated functions. Microbiology 151:1095-1111.
31. Threlfall, E. J., and N. Woodford. 1995. Plasmid profile typing and plasmid fingerprinting. Methods Mol. Biol. 46:225-236.
32. Toh, H., K. Oshima, A. Toyoda, Y. Ogura, T. Ooka, H. Sasamoto, S. H. Park, S. Iyoda, K. Kurokawa, H. Morita, K. Itoh, T. D. Taylor, T. Hayashi, and M. Hattori. 2010. Complete genome sequence of the wild-type commensal Escherichia coli strain SE15, belonging to phylogenetic group B2. J. Bacteriol. 192:1165-1166.
33. Woodford, N., A. Carattoli, E. Karisik, A. Underwood, M. J. Ellington, and D. M. Livermore. 2009. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob. Agents Chemother. 53:4472-4482.
34. Yumuk, Z., G. Afacan, M. H. Nicolas-Chanoine, A. Sotto, and J. P. Lavigne. 2008. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 62:284-288.